Eli Lilly (LLY) and Novo Nordisk (NVO) have become hot stocks over the past year thanks to their blockbuster GLP-1 drugs to treat obesity. Over the last year, Lilly and Novo shares are up 72% and 44%, respectively. By market cap, Novo is the largest company in Europe while Lilly ranks eighth among US companies